Original Article(s)
Vol. 13 (2025)
Evolution of mammographic screenings and impact on early diagnosis of breast cancer at the University Hospital of Alessandria: a comparison between 2019 and 2023
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 8 January 2025
Accepted: 11 March 2025
Accepted: 11 March 2025
102
Views
26
Downloads
Authors
Background: Breast Cancer (BC) is one of the most common cancers in women, with its incidence increasing with age. Early detection through screening programs is crucial for improving treatment outcomes. Materials and Methods: this study evaluates the outcomes of the Breast Unit at the University Hospital of Alessandria (AOU AL), established in 2020, in collaboration with the "Prevenzione Serena" Breast Cancer Screening Service of Local Health Authority of Alessandria and compares data from 2019 and 2023 to assess improvements in early detection and surgical interventions Seven women were treated in 2019, whereas 51 received surgery in 2023. Data from the Oncological Screening Information System (SIOSOweb), Trackcare InterSystem, and the Quality of Breast Cancer Treatment Form (SQTM) were analyzed. Results: the results show an increase in screening participation (46.8% in 2019 to 58% in 2023) and an increase in early-stage tumor detection. Smaller tumors (pT1) were detected more frequently, rising from 50% in 2019 to 83% in 2023. Sentinel Lymph Node Biopsy (SNB) remained the most common procedure, although node-free tumors slightly decreased. Conclusions: the data highlight the importance of the "Prevenzione Serena" screening program and the establishment of the Breast Unit at AOU AL in improving the early diagnosis and management of BC. The study underscores the significance of a multidisciplinary approach to BC care and suggests that continuous investment in screening and specialized units is essential for improving patient outcomes.
Downloads
Download data is not yet available.
Citations
1. American Cancer Society. Breast Cancer Facts & Figures 2024-2025. 2024. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2024/breast-cancer-facts-and-figures-2024.pdf
2. Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond) 2022;83:1-7. DOI: https://doi.org/10.12968/hmed.2021.0459
3. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. DOI: https://doi.org/10.3322/caac.21660
4. Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 2022;66:15-23. DOI: https://doi.org/10.1016/j.breast.2022.08.010
5. Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore) 2024;103:e36905. DOI: https://doi.org/10.1097/MD.0000000000036905
6. Iatrakis G, Zervoudis S. Epidemiology of ductal carcinoma in situ. Chirurgia (Romania) 2021;116:S15-21. DOI: https://doi.org/10.21614/chirurgia.116.5.suppl.S15
7. Roheel A, Khan A, Anwar F, et al. Global epidemiology of breast cancer based on risk factors: a systematic review. Front Oncol 2023;13:1240098. DOI: https://doi.org/10.3389/fonc.2023.1240098
8. Kolak A, Kamińska M, Sygit K, Budny A. Primary and secondary prevention of breast cancer. Ann Agric Environ Med 2017;24:549-53. DOI: https://doi.org/10.26444/aaem/75943
9. Hayek S, Enav T, Shohat T, Keinan-Boker L. Factors associated with breast cancer screening in a country with national health insurance: did we succeed in reducing healthcare disparities? J Women’s Health 2017;26:159-68. DOI: https://doi.org/10.1089/jwh.2016.5835
10. Biganzoli L, Cardoso F, Beishon M, et al. The requirements of a specialist breast centre. Breast 2020;51:65-84. DOI: https://doi.org/10.1016/j.breast.2020.02.003
11. Tinterri C, Gentile D, Caruso F. Senonetwork Italia breast centre responders. BRCA testing for patients treated in Italy: a national survey of breast centers associated with Senonetwork. Curr Oncol 2024;31:3815-25. DOI: https://doi.org/10.3390/curroncol31070282
12. Presidenza del Consiglio dei Ministri. Rep. Atti N.185/CSR del 18 dicembre 2014. 2014. Available from: https://www.osservatorionazionalescreening.it/sites/default/files/allegati/DOC_045999_185%20%20CSR%20PUNTO%204.pdf
13. EUSOMA. The requirements of a specialist breast unit. Eur. J. Cancer 2000;36:2288-93. DOI: https://doi.org/10.1016/S0959-8049(00)00180-5
14. APS Senonetwork Italia. Available from: https://www.senonetwork.it/centri-di-senologia/elenco-centri-di senologia/Piemonte/AO+Alessandria/4-4118-22562-
15. Di Girolamo C, Cammarata G, Giordano L, et al. Contextual and individual inequalities in breast cancer screening participation and outcomes in Turin (North-West Italy). NPJ Breast Cancer 2024;10:51. DOI: https://doi.org/10.1038/s41523-024-00660-4
16. Ouanhnon L, Rougé Bougat ME, Lamy S, et al. Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France. BMJ Open 2022;12:e055363. DOI: https://doi.org/10.1136/bmjopen-2021-055363
17. Ferrante G, Castagno R, Rizzolo R, et al. A comparison of diagnostic indicators of cervical cancer screening among women accessing through volunteer organisations and those via the organised programme in Turin (Piedmont Region, Northern Italy). Epidemiol Prev 2020;44:115-23.
18. Giorgi Rossi P, Djuric O, Navarra S. Geographic inequalities in breast cancer in Italy: trend analysis of mortality and risk factors. Int J Environ Res Public Health 2020;17:4165. DOI: https://doi.org/10.3390/ijerph17114165
19. Fuller MS, Lee CI, Elmore JG. Breast cancer screening: an evidence-based update. Med Clin North Am 2015;99:451-68. DOI: https://doi.org/10.1016/j.mcna.2015.01.002
20. Chang CC, Ho TC, Lien CY, et al. The effects of prior mammography screening on the performance of breast cancer detection in Taiwan. Healthcare (Basel) 2022;10:1037. DOI: https://doi.org/10.3390/healthcare10061037
21. Istituto Superiore di Sanità (ISS). Linee guida per lo screening e la diagnosi del tumore della mammella. 2024. Available from: https://www.gisma.it/wp-content/uploads/2024/10/LG-507_Screening-e-diagnosi-tumore-mammella_parte-2.pdf
22. Van der Poort EKJ, van Ravesteyn NT, van den Broek JJ, et al. The early detection of breast cancer using liquid biopsies: model estimates of the benefits, harms, and costs. Cancers 2022;14:2951. DOI: https://doi.org/10.3390/cancers14122951
23. Gruppo Italiano Screening Mammografico (GISMA). Le procedure diagnostiche pre-operatorie delle lesioni mammarie. 2024. Available from: https://www.gisma.it/wp-content/uploads/2024/05/esec_BOOK_PROCEDURE-DIAGNOSTICHE-PREOPERATORIE-_7mag2024.pdf
24. Jagsi R, Mason G, Overmoyer BA, et al. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Res Treat 2022;192:235-43. DOI: https://doi.org/10.1007/s10549-021-06434-x
25. Jonczyk MM, Jean J, Graham R, Chatterjee A. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat 2019;173:267-74. DOI: https://doi.org/10.1007/s10549-018-5018-1
26. Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO Guideline. 2021;39:1485-505. DOI: https://doi.org/10.1200/JCO.20.03399
27. Shien T, Iwata H. Adjuvant and neoadjuvant therapy for breast cancer. Japanese Journal of Clinical Oncology 2020;50:225-9. DOI: https://doi.org/10.1093/jjco/hyz213
28. De Rose F, Meduri B, De Santis MC. Rethinking breast cancer follow-up based on individual risk and recurrence management. Cancer Treat Rev. 2022;109:102434. DOI: https://doi.org/10.1016/j.ctrv.2022.102434
29. Cardoso F, Kyriakides S, Ohno S. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO Guidelines Committee. Ann Oncol 2019;30:1194-220. DOI: https://doi.org/10.1093/annonc/mdz173
30. Fico N, Di Grezia G, Cuccurullo V. Breast imaging physics in mammography (part I). Diagnostics (Basel) 2023;13:3227. DOI: https://doi.org/10.3390/diagnostics13203227
How to Cite
Evolution of mammographic screenings and impact on early diagnosis of breast cancer at the University Hospital of Alessandria: a comparison between 2019 and 2023. (2025). Working Paper of Public Health, 13. https://doi.org/10.4081/wpph.2025.10221
Copyright (c) 2025 Maria Caterina Canepa, Roberta Pizzolo, Sabrina Peroo, Mariacaterina Maconi, Giorgia Piceni, Marta Betti, Serena Penpa, Antonio Maconi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
